PRESS DIGEST- New York Times business news - Nov 30

Follow us on Google News:
 PRESS DIGEST- New York Times business news - Nov 30
Image source: ©2022 Kalkine Media®

Nov 30 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.

- Eisai Co Ltd and Biogen Inc released new data Tuesday evening, offering the first detailed look at the effects of the experimental Alzheimer's drug, lecanemab, suggesting that the treatment slowed cognitive decline for people in the early stages of the disease but also caused some patients to experience brain swelling or brain bleeding.

- Congressional leaders said on Tuesday that they would pass legislation to prevent a nationwide rail strike, agreeing with U.S. President Biden that a strike could shut down a critical piece of the economy and potentially inflame an inflation problem in the United States.

- The South Carolina Supreme Court on Tuesday ordered Mark Meadows, a White House chief of staff under former U.S. President Donald J. Trump, to testify in the criminal investigation into efforts by Mr. Trump and his allies to overturn his November 2020 election loss in Georgia. (Compiled by Bengaluru newsroom)


The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Featured Articles